These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2225010)

  • 1. [Passive hemagglutination assay (PHA) in detection of antibodies against measles].
    Li ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1990 Aug; 11(4):247-50. PubMed ID: 2225010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of passive hemagglutination assay of measles and utilization in serological diagnosis].
    Zhang R
    Zhonghua Liu Xing Bing Xue Za Zhi; 1990 Apr; 11(2):103-7. PubMed ID: 2372818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the sensitivity and reproducibility of passive haemagglutination test for the quantitation of measles-specific antibodies.
    Kumar S; Sokhey J; Sood DK; Singh S; Singh H
    Acta Virol; 1994 Oct; 38(5):277-83. PubMed ID: 7726002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of measles antibodies using the indirect hemagglutination test].
    Smorodinova IP; Miroshnikova NK; Kashkina GB; Baiar GA; Noskov FS
    Tr Inst Im Pastera; 1981; 56():115-7. PubMed ID: 6764965
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of the passive hemagglutination test for determining immunity to the measles virus].
    Sokhin AA; Popov VF; Sliusar' LI; Iunasova TN
    Lab Delo; 1986; (3):172-5. PubMed ID: 2421091
    [No Abstract]   [Full Text] [Related]  

  • 6. [A study on measles immune status by ELISA].
    Li GQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Apr; 10(2):105-8. PubMed ID: 2736614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population screening test for antibody to measles virus.
    Friedman MG
    Isr J Med Sci; 1981 Nov; 17(11):1045-50. PubMed ID: 7319792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Control over the postvaccinal measles immunity status using the indirect hemagglutination test with lyophilized diagnostic agents].
    Sokhin AA; Sliuar' LI; Smorodinova IP; Rodomskaia FS; Makarova EN
    Tr Inst Im Pastera; 1981; 56():121-3. PubMed ID: 7187542
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison between the plaque reduction neutralization test and the hemagglutination inhibition test in determination of human anti-measles antibodies].
    Kong J; Guo SH; Ze WY
    Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Apr; 17(2):105-7. PubMed ID: 8758407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute sclerosing panencephalitis: detection of measles antibody in serum and cerebrospinal fluid by enzyme-linked immunosorbent assay, complement fixation and hemagglutination inhibition.
    Ferrante P; Achilli G; Gerna G; Bergamini F
    Microbiologica; 1987 Jan; 10(1):111-8. PubMed ID: 3574144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and reproducibility of enzyme immunoassay for measles virus antibody detection.
    Rapicetta M; Proietti E; Morace G; Macchia T
    Microbiologica; 1983 Jul; 6(3):239-45. PubMed ID: 6355776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of a trial of an erythrocyte measles diagnostic agent in public health institutions].
    Polzik TP; Kashkina GB; Andrianova DP; Bol'shakova SL; Petrova MA
    Tr Inst Im Pastera; 1981; 56():112-4. PubMed ID: 6764964
    [No Abstract]   [Full Text] [Related]  

  • 13. Serological survey of measles in Yemen in 1985.
    Strauss J; Dobahi SS; Danes L; Kopecký K; Svandová E
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(1):71-4. PubMed ID: 2723425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of measles antibodies and virus-specific IgM in the indirect hemagglutination test in disseminated sclerosis and other CNS diseases].
    Kantorovich RA; Volodina NI; Kir'iakov VA; Khatenever ML; Astaf'ev GM
    Tr Inst Im Pastera; 1981; 56():118-21. PubMed ID: 6764966
    [No Abstract]   [Full Text] [Related]  

  • 15. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
    Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive hemagglutination test for measles immunity and serodiagnosis.
    Sakata H; Sugiura A
    J Clin Microbiol; 1988 Apr; 26(4):636-40. PubMed ID: 3130389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA; Harry TO
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the occurrence and properties of measles virus antibodies by the ELISA method].
    Jankowski M
    Med Dosw Mikrobiol; 1986; 38(1):23-30. PubMed ID: 3713367
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of measles-specific IgM antibodies: comparison of 2-mercaptoethanol treatment, density gradient centrifugation, protein A-sepharose affinity chromatography, ion-exchange chromatography and haemadsorption techniques.
    Tischer A; Gerike E
    Acta Virol; 1986 Sep; 30(5):373-80. PubMed ID: 2878584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.